HNF1B糖尿病患者的胆道异常
研究对赫尔辛基大学医院辖区14例HNF1B突变患者行上腹部MRI和MRCP,系统评估胆道异常。7例(50%)发现胆管结构异常,6例为胆总管囊肿,后者通常被认为有恶变潜能。结论认为胆道结构异常在HNF1B突变携带者中常见,其相关胆总管囊肿的恶变潜能需进一步研究。
要点
- 14例HNF1B突变患者中7例(50%)经MRI/MRCP发现胆道结构异常。
- 6例患者存在胆总管囊肿,该病变通常被认为有恶变潜能。
- HNF1B相关胆总管囊肿的恶变潜能需进一步研究。
核心结论
- 胆道系统结构异常在HNF1B突变携带者中常见。
- HNF1B相关胆总管囊肿的恶变潜能需进一步研究。
研究设计与样本
- 对赫尔辛基大学医院辖区14例HNF1B突变患者行上腹部MRI和MRCP评估,并结合血样与临床病史补充个体表型资料。
主要发现
- 14例患者中7例(50%)发现胆管结构异常。
- 6例患者存在胆总管囊肿。
局限性
- HNF1B相关胆总管囊肿的恶变潜能需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The clinical spectrum of organogenetic anomalies associated with HNF1B mutations is heterogeneous. Besides cystic kidney disease, diabetes, and various other manifestations, odd cases of mainly neonatal and posttransplantation cholestasis have been described. The biliary phenotype is incompletely defined. OBJECTIVE: To systematically characterize HNF1B-related anomalies in the bile ducts by imaging with magnetic resonance imaging (MRI) or magnetic resonance cholangiopancreatography (MRCP). SETTING AND PATIENTS: Fourteen patients with HNF1B mutations in the catchment area of the Helsinki University Hospital were evaluated with upper abdominal MRI and MRCP. Blood samples and clinical history provided supplemental data on the individual phenotype. MAIN OUTCOME MEASURE(S): Structural anomalies in the biliary system, medical history of cholestasis, other findings in abdominal organs, diabetes and antihyperglycemic treatment, hypomagnesemia, and hyperuricemia. RESULTS: Structural anomalies of the bile ducts were found in seven of 14 patients (50%). Six patients had choledochal cysts, which are generally considered premalignant. CONCLUSIONS: Structural anomalies of the biliary system were common in HNF1B mutation carriers. The malignant potential of HNF1B-associated choledochal cysts warrants further studies.
引用
- Kettunen JLT, Parviainen H, Miettinen PJ, et al. Biliary Anomalies in Patients With HNF1B Diabetes. J Clin Endocrinol Metab. 2017. PMID: 28324003. doi:10.1210/jc.2017-00061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。